The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
The relevance of animal models in multiple sclerosis research
Open accessAbstract
Multiple Sclerosis (MS) is a complex disease with an unknown etiology and no effective cure, despite decades of extensive research that led to the development of several partially effective treatments. Researchers have only limited access to early and immunologically active MS tissue samples, and the modification of experimental circumstances is much more restricted in human studies compared to studies in animal models. For these reasons, animal models are needed to clarify the underlying immune-pathological mechanisms and test novel therapeutic and reparative approaches. It is not possible for a single mouse model to capture and adequately incorporate all clinical, radiological, pathological and genetic features of MS. The three most commonly studied major categories of animal models of MS include: (1) the purely autoimmune experimental autoimmune/allergic encephalomyelitis (EAE); (2) the virally induced chronic demyelinating disease models, with the main model of Theiler's Murine Encephalomyelitis Virus (TMEV) infection and (3) toxin-induced models of demyelination, including the cuprizone model and focal demyelination induced by lyso-phosphatidyl choline (lyso-lecithine). EAE has been enormously helpful over the past several decades in our overall understanding of CNS inflammation, immune surveillance and immune-mediated tissue injury. Furthermore, EAE has directly led to the development of three approved medications for treatment in multiple sclerosis, glatiramer acetate, mitoxantrone and natalizumab. On the other hand, numerous therapeutical approaches that showed promising results in EAE turned out to be either ineffective or in some cases harmful in MS. The TMEV model features a chronic-progressive disease course that lasts for the entire lifespan in susceptible mice. Several features of MS, including the role and significance of axonal injury and repair, the partial independence of disability from demyelination, epitope spread from viral to myelin epitopes, the significance of remyelination has all been demonstrated in this model. TMEV based MS models also feature several MRI findings of the human disease. Toxin-induced demyelination models has been mainly used to study focal demyelination and remyelination. None of the three main animal models described in this review can be considered superior; rather, they are best viewed as complementary to one another. Despite their limitations, the rational utilization and application of these models to address specific research questions will remain one of the most useful tools in studies of human demyelinating diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Self-citationRevised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,574
Induction and effector functions of TH17 cells
Bettelli, E., Korn, T., Oukka, M., & Kuchroo, V. K. (2008) · Nature · doi:10.1038/nature07036 · Cited by 1,216
Environmental risk factors for multiple sclerosis. Part I: The role of infection
Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21117 · Cited by 1,042
Matsushima, G. K., & Morell, P. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00385.x · Cited by 984
Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M., Schröder, R., Deckert, M., Schmidt, S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.393 · Cited by 951
Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis
Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 921
A Pathogenic Role for Myelin-Specific Cd8+ T Cells in a Model for Multiple Sclerosis
Huseby, E. S., Liggitt, D., Brabb, T., Schnabel, B., Öhlén, C., & Goverman, J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.669 · Cited by 659
OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS
Rivers, T. M., Sprunt, D. H., & Berry, G. P. (1933) · Journal of Experimental Medicine · doi:10.1084/jem.58.1.39 · Cited by 643
Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination
Lipton, H. L. (1975) · Infection and Immunity · doi:10.1128/iai.11.5.1147-1155.1975 · Cited by 607
CLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSIS
SIBLEY, W. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92801-6 · Cited by 594
Pettinelli, C. B., & McFarlin, D. E. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.4.1420 · Cited by 588
Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading
Miller, S. D., Vanderlugt, C. L., Begolka, W. S., Pao, W., Yauch, R. L., Neville, K. L., Katz-Levy, Y., Carrizosa, A., & Kim, B. S. (1997) · Nature Medicine · doi:10.1038/nm1097-1133 · Cited by 565
Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis: A Prospective Study
Ascherio, A., Munger, K. L., Lennette, E. T., Spiegelman, D., Hernán, M. A., Olek, M. J., Hankinson, S. E., & Hunter, D. J. (2001) · JAMA · doi:10.1001/jama.286.24.3083 · Cited by 549
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-7-555_1 · Cited by 548
Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases
Neumann, H. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02154-9 · Cited by 480
Steinman, L., & Zamvil, S. S. (2006) · Annals of Neurology · doi:10.1002/ana.20913 · Cited by 479
The origin and application of experimental autoimmune encephalomyelitis
Baxter, A. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2190 · Cited by 458
Myelin Antigen-Specific CD8+ T Cells Are Encephalitogenic and Produce Severe Disease in C57BL/6 Mice
Sun, D., Whitaker, J. N., Huang, Z., Liu, D., Coleclough, C., Wekerle, H., & Raine, C. S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7579 · Cited by 444
ENCEPHALOMYELITIS ACCOMPANIED BY MYELIN DESTRUCTION EXPERIMENTALLY PRODUCED IN MONKEYS
Rivers, T. M., & Schwentker, F. F. (1935) · Journal of Experimental Medicine · doi:10.1084/jem.61.5.689 · Cited by 435
McFarlin, D. E., & McFarland, H. F. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211043071905 · Cited by 416
Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions
Hauser, S. L., Bhan, A. K., Gilles, F., Kemp, M., Kerr, C., & Weiner, H. L. (1986) · Annals of Neurology · doi:10.1002/ana.410190610 · Cited by 399
Hiscock, C., & ISDALE, I. C. (1964) · PubMed · Cited by 370
(2004) · Elsevier eBooks · doi:10.1016/b978-0-12-439510-7.x5051-7 · Cited by 311
Shields, S. A., Gilson, J. M., Blakemore, W. F., & Franklin, R. J. M. (1999) · Glia · doi:10.1002/(sici)1098-1136(199910)28:1<77::aid-glia9>3.0.co;2-f · Cited by 287
Remyelination in Experimental Models of Toxin-Induced Demyelination
Blakemore, W. F., & Franklin, R. J. M. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-73677-6_8 · Cited by 275
Hall, S. M. (1972) · Journal of Cell Science · doi:10.1242/jcs.10.2.535 · Cited by 274
Experimental allergic encephalomyelitis: A misleading model of multiple sclerosis
Sriram, S., & Steiner, I. (2005) · Annals of Neurology · doi:10.1002/ana.20743 · Cited by 264
Persistent infection of oligodendrocytes in Theiler's virus‐induced encephalomyelitis
Rodriguez, M., Leibowitz, J. L., & Lampert, P. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130409 · Cited by 243
Self-citationTheiler's Virus-Induced Demyelination: Prevention by Immunosuppression
Lipton, H. L., & Dal Canto, M. C. (1976) · Science · doi:10.1126/science.176726 · Cited by 238
Epidemiologic contributions to multiple sclerosis: An overview
Kurtzke, J. F. (1980) · Neurology · doi:10.1212/wnl.30.7_part_2.61 · Cited by 236
The pathology of multiple sclerosis
Lucchinetti, C. F., Parisi, J., & Bruck, W. (2005) · Neurologic Clinics · doi:10.1016/j.ncl.2004.09.002 · Cited by 208
A virus-induced molecular mimicry model of multiple sclerosis
Olson, J. K., Croxford, J. L., Calenoff, M. A., Dal Canto, M. C., & Miller, S. D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13032 · Cited by 203
The CD4–Th1 model for multiple sclerosis: a crucial re-appraisal
Lassmann, H., & Ransohoff, R. M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.01.007 · Cited by 203
Rivera-Quiñones, C., McGavern, D., Schmelzer, J. D., Hunter, S. F., Low, P. A., & Rodriguez, M. (1998) · Nature Medicine · doi:10.1038/nm0298-187 · Cited by 196
Self-citationEfficient central nervous system remyelination requires T cells
Bieber, A. J., Kerr, S., & Rodriguez, M. (2003) · Annals of Neurology · doi:10.1002/ana.10578 · Cited by 196
Self-citationMcFarlin, D. E., & McFarland, H. F. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211113072005 · Cited by 189
Remyelination of mouse spinal cord axons demyelinated by local injection of lysolecithin
Jeffery, N. D., & Blakemore, W. F. (1995) · Journal of Neurocytology · doi:10.1007/bf01191213 · Cited by 183
Lipton, H. L., Twaddle, G., & Jelachich, M. L. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2525-2533.1995 · Cited by 180
Integrating risk factors: HLA-DRB1*1501 and Epstein–Barr virus in multiple sclerosis
De Jager, P. L., Simon, K. C., Munger, K. L., Rioux, J. D., Hafler, D. A., & Ascherio, A. (2008) · Neurology · doi:10.1212/01.wnl.0000294325.63006.f8 · Cited by 176
A virus-induced molecular mimicry model of multiple sclerosis
Olson, J. K., Croxford, J. L., Calenoff, M. A., Dal Canto, M. C., & Miller, S. D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113032 · Cited by 174
Micro Mounts, Reverse and Converse
Jacot, A. P. (1934) · Science · doi:10.1126/science.80.2066.122-a · Cited by 172
Suzuki, K., & KIKKAWA, Y. (1969) · PubMed · Cited by 167
Tsunoda, I., & Fujinami, R. S. (2002) · Springer Seminars in Immunopathology · doi:10.1007/s00281-002-0105-z · Cited by 164
Demyelination induced by Theiler's virus: influence of the H-2 haplotype.
Rodriguez, M., & David, C. S. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.3.2145 · Cited by 156
Self-citationTheiler's murine encephalomyelitis: a model of demyelination and persistence of virus.
Rodriguez, M., Oleszak, E. L., & Leibowitz, J. L. (1987) · PubMed · Cited by 143
Self-citationKatz‐Levy, Y., Neville, K. L., Girvin, A. M., Vanderlugt, C. L., Pope, J. G., Tan, L., & Miller, S. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7292 · Cited by 133
Autoimmunity and Autoimmune Diseases
Paul, W. E., Schwartz, R. S., & Datta, S. (1989) · Cited by 132
McGavern, D. B., Murray, P. D., Rivera-Quiñones, C., Schmelzer, J. D., Low, P. A., & Rodriguez, M. (2000) · Brain · doi:10.1093/brain/123.3.519 · Cited by 130
Self-citationKabat, E. A., Wolf, A., & Bezer, A. E. (1946) · Science · doi:10.1126/science.104.2703.362 · Cited by 115
Canto, M. C. D., Kim, B., Miller, S. D., & Melvold, R. W. (1996) · Methods · doi:10.1006/meth.1996.0123 · Cited by 102
Pirko, I., Ćirić, B., Gamez, J. D., Bieber, A. J., Warrington, A. E., Johnson, A. J., Hanson, D. P., Pease, L. R., Macura, S. I., & Rodriguez, M. (2004) · The FASEB Journal · doi:10.1096/fj.04-2026fje · Cited by 96
Self-citationWolf, A., Kabat, E. A., & Bezer, A. E. (1947) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-194710000-00003 · Cited by 90
Multiple Sclerosis as a Neuronal Disease
Waxman, S. G. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.22 · Cited by 79
Pathogenesis of multiple sclerosis
Poser, C. M. (1986) · Acta Neuropathologica · doi:10.1007/bf00687954 · Cited by 75
Ure, D., & Rodriguez, M. (2002) · The FASEB Journal · doi:10.1096/fj.01-1023fje · Cited by 67
Self-citationSpongiform encephalopathy induced in rats and guinea pigs by cuprizone
Carlton, W. W. (1969) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(69)90057-4 · Cited by 64
Absence of perforin expression confers axonal protection despite demyelination
Howe, C. L., Steinmetz, J. D., & Rodriguez, M. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.001 · Cited by 64
Self-citationFunctional Activation of Myelin-Specific T Cells by Virus-Induced Molecular Mimicry
Olson, J. K., Eagar, T. N., & Miller, S. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2719 · Cited by 61
Cuprizone neurotoxicity in the rat: morphologic observations
Love, S. (1988) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(88)90127-x · Cited by 54
Zoecklein, L. J., Pavelko, K. D., Gamez, J. D., Papke, L. M., McGavern, D. B., Ure, D., Njenga, M. K., Johnson, A. J., Nakane, S., & Rodriguez, M. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00029.x · Cited by 48
Self-citationMultiple Sclerosis As A Neuronal Disease
(2005) · Elsevier eBooks · doi:10.1016/b978-0-12-738761-1.x5000-7 · Cited by 40
Acute hemorrhagic demyelination in a murine model of multiple sclerosis
Pirko, I., Suidan, G. L., Rodriguez, M., & Johnson, A. J. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-31 · Cited by 39
Self-citationGenetically Dominant Spinal Cord Repair in a Murine Model of Chronic Progressive Multiple Sclerosis
Bieber, A. J., Ure, D., & Rodriguez, M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.1.46 · Cited by 34
Self-citationDeep gray matter T2 hypointensity correlates with disability in a murine model of MS
Pirko, I., Johnson, A. J., Lohrey, A. K., Chen, Y., & Ying, J. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.12.013 · Cited by 33
Self-citationPirko, I., Gamez, J. D., Johnson, A. J., Macura, S. I., & Rodriguez, M. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.09.037 · Cited by 33
Self-citationA FATAL NEURO-PARALYTIC ACCIDENT OF ANTIRABIES TREATMENT.
Stuart, G., & Krikorian, K. S. (1930) · The Lancet · doi:10.1016/s0140-6736(00)70779-3 · Cited by 27
Advances in multiple Sclerosis and Experimental Demyelinating Diseases
Rodriguez, M. (2007) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-73677-6 · Cited by 21
Self-citationMultiple Sclerosis: Pathogenesis and MR Imaging Features of T1 Hypointensities in Murine Model
Pirko, I., Nolan, T. K., Holland, S. K., & Johnson, A. J. (2008) · Radiology · doi:10.1148/radiol.2463070338 · Cited by 20
Self-citationContrasting murine models of MS.
Nelson, A. L. A., Bieber, A. J., & Rodriguez, M. (2004) · PubMed · Cited by 20
Self-citationExperimental Models of Virus-Induced Demyelination
Bieber, A. J., & Rodriguez, M. (2004) · Elsevier eBooks · doi:10.1016/b978-012439510-7/50097-8 · Cited by 9
Self-citationRemyelination as Neuroprotection
Howe, C. L., & Rodriguez, M. (2005) · Elsevier eBooks · doi:10.1016/b978-012738761-1/50028-6 · Cited by 8
Self-citationDiagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cited by
Multiple sclerosis: experimental models and reality
Lassmann, H., & Bradl, M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1631-4 · Cited by 525
Oxidative and nitrative stress in neurodegeneration
Cobb, C. A., & Cole, M. P. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.020 · Cited by 298
The pathogenic role of the inflammasome in neurodegenerative diseases
Freeman, L. C., & Ting, J. P. ‐. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13217 · Cited by 276
The role of antigen presenting cells in multiple sclerosis
Chastain, E. M. L., Duncan, D. S., Rodgers, J. M., & Miller, S. D. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.008 · Cited by 266
Mechanisms of white matter damage in multiple sclerosis
Lassmann, H. (2014) · Glia · doi:10.1002/glia.22597 · Cited by 191
Metadata
- Authors
- Denic, A., Johnson, A. J., Bieber, A. J., Warrington, A. E., Rodriguez, M., & Pirko, I.
- Venue
- Pathophysiology
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 18
- Issue
- 1
- Pages
- 21-29
- ISSN
- 0928-4680 (ISSN-L)
- OpenAlex
- W2026951449
- Cited by
- 298
- References
- 73
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.